Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 5
2005 4
2006 2
2007 4
2008 5
2009 9
2010 10
2011 8
2012 8
2013 7
2014 9
2015 13
2016 8
2017 9
2018 10
2019 9
2020 20
2021 20
2022 18
2023 11
2024 8
2025 10

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Classification Criteria for Vogt-Koyanagi-Harada Disease.
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug;228:205-211. doi: 10.1016/j.ajo.2021.03.036. Epub 2021 Apr 9. Am J Ophthalmol. 2021. PMID: 33845018 Free PMC article.
Classification Criteria for Behçet Disease Uveitis.
Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature (SUN) Working Group. Am J Ophthalmol. 2021 Aug;228:80-88. doi: 10.1016/j.ajo.2021.03.058. Epub 2021 May 11. Am J Ophthalmol. 2021. PMID: 33845008 Free PMC article.
Behçet Uveitis.
Cunningham ET Jr, Tugal-Tutkun I, Khairallah M, Okada AA, Bodaghi B, Zierhut M. Cunningham ET Jr, et al. Among authors: okada aa. Ocul Immunol Inflamm. 2017 Feb;25(1):2-6. doi: 10.1080/09273948.2017.1279840. Ocul Immunol Inflamm. 2017. PMID: 28195819 No abstract available.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
COVID Vaccine-Associated Uveitis.
Habot-Wilner Z, Neri P, Okada AA, Agrawal R, Xin Le N, Cohen S, Fischer N, Kilmartin F, Coman A, Kilmartin D. Habot-Wilner Z, et al. Among authors: okada aa. Ocul Immunol Inflamm. 2023 Aug;31(6):1198-1205. doi: 10.1080/09273948.2023.2200858. Epub 2023 May 5. Ocul Immunol Inflamm. 2023. PMID: 37145198 Review.
The standardisation of uveitis nomenclature (SUN) project.
Jabs DA, McCluskey P, Palestine AG, Thorne JE; Standardization of Uveitis Nomenclature (SUN) Working Group. Jabs DA, et al. Clin Exp Ophthalmol. 2022 Sep 27:10.1111/ceo.14175. doi: 10.1111/ceo.14175. Online ahead of print. Clin Exp Ophthalmol. 2022. PMID: 36164924 Free PMC article. Review.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: okada aa. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Reply.
Okada AA, Yamamoto A, Koizumi H, Kano M, Saito M, Maruko I, Sekiryu T, Iida T. Okada AA, et al. Ophthalmology. 2016 Feb;123(2):e13-e14. doi: 10.1016/j.ophtha.2015.08.032. Ophthalmology. 2016. PMID: 26802715 No abstract available.
174 results